Otros idiomas Prothena Corporation plc

Acciones

PRTA

IE00B91XRN20

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 29/04/2024			Varia. Cinco días.	Varia. 1 de enero.
21,19 ^USD	+1,53 %		-0,47 %	-41,69 %

04/03	Prothena nombra a David Ford para el recién creado puesto de Director de Personas	CI
21/02	Prothena Corporation plc anuncia cambios en su Consejo de Administración	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia and Lymphoma	16/04
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma	15/04
Prothena : Director's Report and Financial Statements for Fiscal Year 2023	29/03
Prothena to Participate in Upcoming Healthcare Conferences	05/03
Prothena Names David Ford as Chief People Officer	04/03
Prothena Appoints David Ford to Newly Created Chief People Officer Position	04/03
Prothena Appoints David Ford to Newly Created Chief People Officer	04/03
Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate	21/02
Prothena Corporation plc Announces Board Changes	21/02
Sector Update: Health Care Stocks Gain Pre-Bell Friday	16/02
Prothena Posts Q4 Net Loss as Revenue Slumps	15/02
Prothena: Q4 Earnings Snapshot	15/02
Earnings Flash (PRTA) PROTHENA CORPORATION Reports Q4 Revenue $316,000, vs. Street Est of $2.72M	15/02
Prothena Corporation plc Provides Earnings Guidance for the Year 2024	15/02
Prothena Corporation plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	15/02
Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights	15/02
Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024	08/02
Prothena Provides Updates on PRX012, PRX123, Birtamimab and Portfolio Programs	08/01
Researchers return to Alzheimer's vaccines, buoyed by recent drug success	20/11
Prothena: Q3 Earnings Snapshot	02/11

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Prothena Corporation plc

Acciones

PRTA

IE00B91XRN20

Otros idiomas

Filtros